[1]
“Risk of Osteoporosis in Patients with Crohn’s Disease Not Respond to Infliximab Therapy Undergoing Surgical Intervention”, Indian Journal of Forensic Medicine & Toxicology, vol. 14, no. 1, pp. 968–973, Jan. 2020, doi: 10.37506/ijfmt.v14i1.179.